Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer
The purpose of this study is to evaluate the efficacy of low-dose vitamin C plus herbal medicine on improving the quality of life for metastatic pancreatic cancer patients receiving gemcitabine and nab-paclitaxel chemotherapy.
• • Ability to understand and the willingness to sign a written informed consent document.
‣ Age ≥ 18 years and ≤ 80 years.
⁃ Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
⁃ Histologically or cytologically confirmed metastatic pancreas adenocarcinoma.
⁃ Adequate organ performance based on laboratory blood tests.
⁃ Presence of at least of one measurable lesion in agreement to RECIST criteria.
⁃ Hemoglobin (Hgb) ≥ 8 g/dL.
⁃ The expected survival ≥ 3 months.
⁃ Women of childbearing potential and men must agree to use adequate contraception prior to study entry and for the duration of study participation.